Amyotrophic lateral sclerosis (ALS) is a fatal upper and lower motor neuron degradation disease that leads to progressive myofiber abnormalities (e.g. decreased size and distribution). With recently FDA-cleared treatments, it is critical to identify non-invasive biomarkers of early disease onset, progression and therapy response. In this study, we validate the potential of a recently developed MR Cytography approach to detect myofiber microstructural changes in an ALS mouse model over three time points by comparison to relevant histologic markers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords